Curcumin Loaded-PLGA Nanoparticles Conjugated with Tet-1 Peptide for Potential Use in Alzheimer's Disease

Targeting the brain with PEG–PLGA nanoparticles modified with phage-displayed peptides

(2011) Jingwei Li et al.   BIOMATERIALS

Curcumin and its nano-formulation: The kinetics of tissue distribution and blood–brain barrier penetration

(2011) Yin-Meng Tsai et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Preparation of Peptide-Functionalized Gold Nanoparticles Using One Pot EDC/Sulfo-NHS Coupling

(2011) Dorota Bartczak et al.   LANGMUIR

Dementia: A problem for our age

(2011) Alison Abbott   NATURE

Relationship between the tautomeric structures of curcumin derivatives and their Aβ-binding activities in the context of therapies for Alzheimer's disease

(2010) Daijiro Yanagisawa et al.   BIOMATERIALS

Curcumin-decorated nanoliposomes with very high affinity for amyloid-β1-42 peptide

(2010) Spyridon Mourtas et al.   BIOMATERIALS

A pyrazole curcumin derivative restores membrane homeostasis disrupted after brain trauma

(2010) Sandeep Sharma et al.   EXPERIMENTAL NEUROLOGY

Endocytosis of nanomedicines

(2010) Gaurav Sahay et al.   JOURNAL OF CONTROLLED RELEASE

Curcumin Labeling of Neuronal Fibrillar Tau Inclusions in Human Brain Samples

(2010) Nina Mohorko et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

Inhibition of angiogenesis- and inflammation-inducing factors in human colon cancer cells in vitro and in ovo by free and nanoparticle-encapsulated redox dye, DCPIP

(2010) Fadee G Mondalek et al.   JOURNAL OF NANOBIOTECHNOLOGY

The effect of curcumin (turmeric) onAlzheimer′s disease: An overview

(2009) Shrikant Mishra et al.   Annals of Indian Academy of Neurology

RETRACTED: Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo

(2009) Preetha Anand et al.   BIOCHEMICAL PHARMACOLOGY

Recent developments in Alzheimer's disease therapeutics

(2009) Michael S Rafii et al.   BMC Medicine

Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer

(2009) J. Shaikh et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Current advances in research and clinical applications of PLGA-based nanotechnology

(2009) Jian-Ming Lü et al.   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

Partial Correction of Cystic Fibrosis Defects with PLGA Nanoparticles Encapsulating Curcumin

(2009) Malgorzata S. Cartiera et al.   MOLECULAR PHARMACEUTICS

Synthesis and Modification of Functional Poly(lactide) Copolymers: Toward Biofunctional Materials

(2008) David E. Noga et al.   BIOMACROMOLECULES

Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease

(2008) Leah R Hanson et al.   BMC NEUROSCIENCE

Curcumin protected PC12 cells against beta-amyloid-induced toxicity through the inhibition of oxidative damage and tau hyperphosphorylation

(2008) So-Young Park et al.   FOOD AND CHEMICAL TOXICOLOGY

Curcumin as “Curecumin”: From kitchen to clinic

(2007) Ajay Goel et al.   BIOCHEMICAL PHARMACOLOGY